Search PubMed⌕ Search

Biomedical subjects

K Torizuka

Publications and source records attributed to K Torizuka.

At least 163 records · Page 9Linked to original sources
PubMed1986

[201Tl myocardial scintigraphy and 13N-NH3 positron computed tomography in evaluating myocardial blood flow].

The early distribution of thallium-201 (Tl-201) is related to blood flow within the limits of the physiological range. We examined the ratio of myocardial uptake of Tl-201 to the total dose administered at rest and during exercise, in order to assess myocardial blood flow. The usual dose of Tl-201 (2-3 mCi) was diluted to 20 ml of normal saline and 15 ml were injected intravenously as a bolus. Subsequently the remaining 5 ml were injected in the same manner. Myocardial Tl-201 uptakes after the first dose were comparable to those of the second dose at rest when myocardial uptake immediately before the second injection was subtracted and multiplied by 3 (r = 0.98). This technique was applied during exercise to evaluate coronary reserve. Symptom-limited exercise was performed using a sitting ergometer and the first dose of Tl-201 was administered. After the routine scintigraphy with multiple views was completed, a second dose was given at rest. Myocardial uptake was greater during exercise than at rest by 32.6 +/- 15.1% (mean +/- SD) in 18 normal subjects. This was significantly greater than that of 20 patients with coronary artery disease (5.8 +/- 15.3%; p less than 0.005). Tl-201 scintigraphy has inherent limitations as to its quantitation, while positron scintigraphy using 13N-NH3 has some advantages for calculations. Percent myocardial uptake of 13N during exercise was practically equal to that at rest in six normal subjects (97.1 +/- 25.0%), but it was slightly reduced in patients with coronary artery disease (90.1 +/- 18.2%).(ABSTRACT TRUNCATED AT 250 WORDS)

Coronary Circulation↗
PubMed1986

[Asynchronous wall motion in patients with ischemic heart disease assessed by higher-order harmonics of the Fourier series].

To assess regional cardiac function in patients with ischemic heart disease (IHD), multigated blood-pool studies using higher-order harmonics of the Fourier series were performed for 14 normal persons and 37 patients with IHD. IHD was further divided into IHD (I) (EF greater than or equal to 50%) and IHD (II) (EF less than 50%). A pixel-by-pixel volume curve was simulated using second order harmonics of the Fourier series to create functional images of the following parameters: time to endosystole (TES), peak ejection rate (PER), time to PER (TPE), peak filling rate (PFR), and time to PFR (TPF). TES (SD), TPE (SD), and TPF (SD) were calculated as the standard deviations of left ventricular (LV) histograms of each phase, representing indexes of asynchronous wall motion. An LV volume curve was simulated using third order harmonics to calculate PFR, PFR/PER, and TPF/TPE, representing indexes of diastolic function. TES (SD) was abnormal in 10 cases (50%), and TPE (SD) was abnormal in seven cases (35%) of IHD (II). On the contrary, TPF (SD) was abnormal in three cases (18%) of IHD (I) and 15 cases (75%) of IHD (II), indicating that diastolic asynchronous indexes are more sensitive than systolic asynchronous indexes in detecting IHD. IHD (I) and IHD (II) showed lower PFR (2.32 +/- 0.55, 1.64 +/- 0.46 EDV/sec) and lower PFR/PER (0.84 +/- 0.15, 0.68 +/- 0.26) than those in normals (3.25 +/- 0.98 EDV/sec, 0.99 +/- 0.19), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Cardiac Volume↗
PubMed1985

Septal Q wave in exercise testing: evaluation by single-photon emission computed tomography.

Changes of septal Q waves in lead V5 by exercise were evaluated with single-photon emission computed tomography. Coronary artery disease was present in 66 patients, 48 of whom had left anterior descending coronary artery (LAD) involvement. Forty-one subjects had normal coronary arteries. All patients under investigation were classified into 3 groups: group A (18 patients)--regression of Q amplitude during exercise; group B (48 patients)--progression or no change of Q wave or a new Q wave during exercise; and group C (41 patients)--no Q waves at rest and during exercise. Perfusion defects of the septum were calculated 3-dimensionally and expressed as a percent of the total septum. Seventeen patients (94%) in group A showed septal perfusion defects by exercise and all of them had LAD stenosis. Forty-three patients (90%) in group B showed no septal perfusion defects, but the others with perfusion defects had LAD stenosis. In group C, 23 of 41 patients (56%) had an LAD lesion, of whom 91% showed septal perfusion defects; none of the remaining 18 patients without LAD stenosis showed perfusion defects. The area of septal perfusion defects during exercise was larger in group A (62 +/- 19%) and in group C (52 +/- 19%) than in group B (23 +/- 9%) (groups A vs B, p less than 0.001; groups C vs B, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Coronary Circulation↗
PubMed1985

Clinical application of the 10-MHz electronic linear array scanner.

A 10-MHz electronic linear array real-time scanner was developed. The axial resolution was 0.26 mm at the -20dB ring down point. The display field was 6.0 cm in width. Excellent high-resolution sonograms of the thyroid, breast and other diseases were obtained using this scanner.

Adult↗
PubMed1985

[125I] radioiodinated metaraminol: a new platelet-specific labeling agent.

In our search for a platelet-specific labeling agent, metaraminol (MA), a low-toxic pharmaceutical for the treatment of hypotension and cardiogenic shock, attracted our attention. Its active incorporation and accumulation by platelets have been recognized. At first, the preparation of 125I radioiodinated metaraminol (125I-MA) was carried out using the chloramine-T method. Then, upon the harvest of platelets as platelet-rich plasma (PRP), their labeling with this new radiopharmaceutical was easily performed by incubation for 10 min at 37 degrees C. The cell-labeling efficiency was dependent on cell density, reaching 63.0% +/- 3.1% at 2.4 X 10(9) cells/ml. The specific incorporation of 125I-MA by an active transport system similar to that of 5-hydroxytryptamine (5-HT) as well as by passive diffusion was demonstrated. In in vitro studies, the unaltered state of 125I-MA-labeled platelets with their cellular functions fully retained was estimated. In vivo studies carried out in rabbits with induced thrombi in the femoral artery showed a rather rapid disappearance of the radioactivity from circulating blood, reaching a high thrombus-to-blood activity ratio of 19.8 +/- 4.3 within 30 min of the administration of 125I-MA-labeled autologous platelets. Thus, with the potential availability of 123I, 123I-MA-labeled platelets appear to be a promising agent for thrombus imaging using single-emission computed tomography (CT) studies.

Animals↗
PubMed1985

In vivo kinetics and thrombus accumulation of 67Ga-labeled urokinase.

Highly purified high and low molecular weight urokinase (H-UK and L-UK) were labeled with 67Ga using deferoxamine (DF) as a bifunctional chelating agent. The labeling efficiency was 91.7% for the H-UK, and 90.4% for the L-UK, respectively. The 67Ga labeled UK (67Ga-DF-UK) fully retained the enzymatic activity of the parent UK. Studies on the in vivo behavior of the 67Ga labeled UK in rabbits showed a very rapid blood clearance with half-life of 4 min (67Ga-DF-L-UK) to 8 min (67Ga-DF-H-UK). Studies carried out in rabbits with induced thrombi in the femoral vein showed thrombus-to-blood 67Ga-DF-UK activity ratios, 2h after injection, of 2.00-3.08 for the H-UK, and 0.84-1.65 for the L-UK, respectively, with thrombi aged 4 to 3 days. A dose effect of the 67Ga-DF-H-UK on its thrombus accumulation was observed. Gel chromatographic analysis of plasma samples withdrawn from those animals injected with this radiopharmaceutical revealed a reduction of the 67Ga-DF-UK effectiveness due to complexation with protein inhibitors. This led to formation of high molecular weight complexes which was reflected in the very fast blood clearance. Its implication in thrombus accumulation is discussed. In conclusion, usefulness of DF for labeling UK with 67Ga or 68Ga with no alteration of UK enzymatic properties was demonstrated. The use of 67Ga-DF-UK as a diagnostic or therapeutic radiopharmaceutical is promising.

Animals↗
PubMed1985

The design of a pentavalent 99mTc-dimercaptosuccinate complex as a tumor imaging agent.

In our search for a technetium-tumor seeking agent, the chemical characteristic of polynuclear Ga-citrate attracted our attention. On this basis, we selected the ligand dimercaptosuccinic acid (DMS) and appropriate labeling conditions in the design of 99mTc(V)-DMS. Chemical characterization was performed by thin layer chromatography, electrophoresis, Sephadex column chromatography and spectrophotometric studies at the chemical concentration (99Tc). Biodistribution in mice bearing Ehrlich ascites tumor and scintigraphic images in VX-2 tumor-bearing rabbit, indicated the great applicability of 99mTc(V)-DMS as a new tumor imaging agent. Its distinctive characteristic, different from the kidney imaging agent (99mTc-DMSA) is demonstrated and the biological implication of hydrolytic polynucleation of pentavalent technetium, through an anionic specie Tc(V)O3-(4), in the tumor cell is discussed.

Animals↗
PubMed1985

Iron(III)-nitrilotriacetate: an agent for reducing the time interval of tumor imaging with gallium citrate.

Increasing interest in the short-lived radionuclide 68Ga (t1/2: 68.2 min) has revived basic studies of gallium radiopharmaceuticals. Ga-citrate (Ga-cit), described as a polynuclear complex, possesses great affinity for tumor cells but is also bound by blood transferrin (Tf). Exploitation of reaction-rate differences in metal ion transference from Ga-cit to Tf (slow) and Fe-nitrilotriacetate (Fe-NTA) to Tf (fast) is put to use to attain a proper tumor/tissue ratio within practical time limits. Studies on administration mode, time and dose offered promising results for future 68Ga-cit tomographic studies.

Animals↗